Bulletin
Investor Alert

Cytokinetics Inc.

NAS: CYTK

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209591999/composite

$

37.00

Change

-0.03 -0.08%

Volume

Volume 12,405

Oct 22, 2021, 5:38 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209591999/composite

Previous close

$ 36.21

$ 37.03

Change

+0.82 +2.26%

Day low

Day high

$35.50

$37.09

Open
Open: 36.00

52 week low

52 week high

$14.89

$39.46

Open

Market cap

$3.09B

Average volume

820,190

P/E ratio

N/A

Rev. per Employee

$303,413

EPS

-2.19

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cytk

MarketWatch News on CYTK

  1. Cytokinetics stock price target raised to $36 from $26 at Mizuho

    6:50 a.m. May 11, 2021

    - Tomi Kilgore

  2. Cytokinetics stock price target cut to $26 from $31 at Mizuho

    7:40 a.m. Dec. 14, 2020

    - Tomi Kilgore

  3. A Heart Drug’s Disappointment for Amgen and Cytokinetics

    4:25 p.m. Oct. 8, 2020

    - Barron's Online

  4. Bristol-Myers’ Deal for MyoKardia Spotlights Heart Drugs

    8:00 a.m. Oct. 6, 2020

    - Barron's Online

  5. Cytokinetics started at strong buy with $39 stock price target at Raymond James

    7:22 a.m. July 10, 2020

    - Tomi Kilgore

  6. Cytokinetics started at buy with $31 stock price target at Mizuho

    7:13 a.m. May 5, 2020

    - Tomi Kilgore

  7. The Investment Allure of American Water Works

    10:30 p.m. Jan. 10, 2020

    - Barron's Online

  8. Here’s how Wall Street’s favorite stock picks turned out in 2019

    10:48 a.m. Dec. 21, 2019

    - Philip van Doorn

  9. Top stock picks for 2020: Standout small companies

    11:42 p.m. Dec. 12, 2019

    - Philip van Doorn

  10. These are the top stock picks for 2019 among Wall Street analysts

    8:21 a.m. Jan. 4, 2019

    - Philip van Doorn

  11. Cytokinetics downgraded to equal weight from overweight at Morgan Stanley

    10:22 a.m. Aug. 1, 2018

    - Tomi Kilgore

  12. Cytokinetics shares drop 26% on late-stage ALS drug failure

    9:31 a.m. Nov. 21, 2017

    - Emma Court

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/cytk

Other News on CYTK

  1. The Best Of Backtesting - Week Oct. 4

    10:20 a.m. Oct. 9, 2021

    - Seeking Alpha

  2. Circling Back On Cytokinetics

    6:33 p.m. Oct. 3, 2021

    - Seeking Alpha

  3. Meet members of the 2021 IPO class: life sciences tools (part 1)

    12:07 p.m. Sept. 29, 2021

    - Seeking Alpha

  4. The Best Of Backtesting - Week Aug. 30

    3:51 p.m. Sept. 2, 2021

    - Seeking Alpha

  5. New Strong Sell Stocks for August 31st

    9:07 a.m. Aug. 31, 2021

    - Zacks.com

  6. New Strong Sell Stocks for August 27th

    10:13 a.m. Aug. 27, 2021

    - Zacks.com

  7. New Strong Sell Stocks for August 18th

    9:06 a.m. Aug. 18, 2021

    - Zacks.com

  8. 10-Q: CYTOKINETICS INC

    4:13 p.m. Aug. 6, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  9. Loading more headlines...
/news/pressrelease/company/us/cytk

Press Releases on CYTK

  1. Cytokinetics to Host Analyst & Investor Day on October 7, 2021

    4:01 p.m. Sept. 23, 2021

    - GlobeNewswire

  2. Cytokinetics to Participate in September Investor Conferences

    4:00 p.m. Sept. 8, 2021

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.